- Home
- XENE vs ASB Comparison
XENE vs ASB Comparison
Compare XENE & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | ASB |
|---|---|---|
| Founded | 1996 | 1861 |
| Country | Canada | United States |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.2B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | XENE | ASB |
|---|---|---|
| Price | $52.07 | $28.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | ★ $68.55 | $29.75 |
| AVG Volume (30 Days) | 1.3M | ★ 1.6M |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $311,000.00 | N/A |
| Revenue This Year | N/A | $21.24 |
| Revenue Next Year | $2,496.48 | $8.86 |
| P/E Ratio | ★ N/A | $10.23 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.00 | $22.48 |
| 52 Week High | $62.91 | $29.52 |
Technical Indicators
Market Signals| Indicator | XENE | ASB |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 61.86 |
| Support Level | $39.93 | $27.03 |
| Resistance Level | $59.43 | $29.27 |
| Average True Range (ATR) | 1.71 | 0.52 |
| MACD | -0.16 | 0.11 |
| Stochastic Oscillator | 27.00 | 99.54 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company based in the United States of America. The company, through its subsidiaries, provides a broad array of banking and non-banking products and services to individuals and businesses. The group operates in three reportable segments: Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty segment, which serves a wide range of customers, including larger businesses, developers, not-for-profits, municipalities, and financial institutions by providing lending and deposit solutions as well as support to deliver, fund, and manage such banking solutions.